相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system
Hajime Kato et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2022)
PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34
Diana Ovejero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Serum Phosphate:A Neglected Test in the Clinical Management of Primary Hyperparathyroidism
Elena Castellano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Tumor-Induced Osteomalacia
Pablo Florenzano et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23
Kelly Lauter Roszko et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Burosumab for the Treatment of Tumor-Induced Osteomalacia
Suzanne M. Jan de Beur et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
FGF23 signalling and physiology
Bryan B. Ho et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2021)
Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia
M. Jimenez et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
John A. Glaspy et al.
ADVANCES IN THERAPY (2021)
Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23
Nobuaki Ito et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2021)
Impact of Tenofovir Disoproxil-Induced Fanconi Syndrome on Bone Material Quality: A Case Report
Benjamin Hadzimuratovic et al.
JBMR PLUS (2021)
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Daniel Edmonston et al.
NATURE REVIEWS NEPHROLOGY (2020)
Approach to patients with hypophosphataemia
Pablo Florenzano et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23
Pablo Florenzano et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Skeletal Consequences of Nephropathic Cystinosis
Pablo Florenzano et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper
Khosrow Adeli et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Hypophosphatemia promotes lower rates of muscle ATP synthesis
Dominik H. Pesta et al.
FASEB JOURNAL (2016)
Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
Mary Scott Ramnitz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment
D. Ovejero et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment
Itsuro Endo et al.
ENDOCRINE JOURNAL (2015)
The PTH-Vitamin D-FGF23 axis
Jenny E. Blau et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2015)
Disordered FGF23 and Mineral Metabolism in Children with CKD
Anthony A. Portale et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Evaluation of a new automated chemiluminescence immunoassay for FGF23
Yuichiro Shimizu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Mechanism of FGF23 processing in fibrous dysplasia
Nisan Bhattacharyya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Approach to the Hypophosphatemic Patient
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement
Itsuro Endo et al.
BONE (2008)
A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc
Graciana Jaureguiberry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
How fibroblast growth factor 23 works
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)